PDCD1LG2 and cerebral malaria: Nevertheless, given rising drug resistance, difficulties in generating an efficacious vaccine for malaria and that some treatments such as soluble PD-L2 generate long-term protection with a reduction in the incidence of cerebral malaria, indicate that checkpoint blockade needs to be further explored.